Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.323NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.395NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.153NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.1.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.391NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.448NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.49.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.3.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LB.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GE.1.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.58.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.8.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KP.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDD.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDNNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used